Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial comparing protease inhibitor–based ART to a non-nucleoside reverse transcriptase inhibitor–based ART for clearance of Plasmodium falciparum para…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection, Pf Subclinical Parasitemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-04